Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma

Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma

Scientists are reporting results of the first frontline clinical trial to use targeted therapy to tr...
read more
Diagnosis of eye cancer

Diagnosis of eye cancer

Once a patient present with symptoms of eye diseas...
read more
An Overview of Paraneoplastic Neurologic Syndromes

An Overview of Paraneoplastic Neurologic Syndromes

Paraneoplastic neurological syndromes (or paraneop...
read more
PET imaging tracer proves effective for diagnosing and managing rare CNS B-cell lymphoma

PET imaging tracer proves effective for diagnosing and managing rare CNS B-cell lymphoma

Positron emission tomography (PET) imaging with 68...
read more
Rates of VTE, major bleeding high in primary CNS lymphoma

Rates of VTE, major bleeding high in primary CNS lymphoma

(HealthDay)—For patients with primary central ne...
read more
Combination therapies could help treat fatal lung cancers: Combining a new class of drug with two other compounds can significantly shrink lung tumors in mice and human cancer cells

Combination therapies could help treat fatal lung cancers: Combining a new class of drug with two other compounds can significantly shrink lung tumors in mice and human cancer cells

Combining a new class of drug with two other compo...
read more
Turbocharging the body’s natural killer cells to defeat cancer

Turbocharging the body’s natural killer cells to defeat cancer

Natural Killer (NK) cells have long been the soldi...
read more
Treatment doctor tested on himself can put others into remission: Research identifies therapeutic target for Castleman disease patients resistant to approved therapy

Treatment doctor tested on himself can put others into remission: Research identifies therapeutic target for Castleman disease patients resistant to approved therapy

Five years ago, David C. Fajgenbaum, MD, MBA, MSc,...
read more
Researchers unlock cancer cells’ feeding mechanism, central to tumor growth: The findings could lead to new treatments by blocking tumor growth at its roots

Researchers unlock cancer cells’ feeding mechanism, central to tumor growth: The findings could lead to new treatments by blocking tumor growth at its roots

An international team led by researchers from the ...
read more
Study in mice advances combination immune therapy for ovarian cancer: Two FDA-approved drugs significantly extend survival time in mouse model of deadly gynecologic disease

Study in mice advances combination immune therapy for ovarian cancer: Two FDA-approved drugs significantly extend survival time in mouse model of deadly gynecologic disease

Delivering two federally approved immunity-alterin...
read more
1 2 3